Figure 1From: Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II studyTNM stage distribution in 68 patients. The American Joint Committee TNM stage was II in 14 (20.6%) patients, III in 32 (47.1%), and IVa in 22 (32.3%), respectively.Back to article page